Last reviewed · How we verify
NCT03332927
Effect of Egg Consumption on Cardiometabolic Health in Prediabetic Subjects.
NA trial testing Egg based breakfast foods in PreDiabetes in 39 participants. Completed in 15 August 2018.
15 August 2018
Quick facts
| Lead sponsor | Midwest Center for Metabolic and Cardiovascular Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 39 |
| Start date | 25 October 2017 |
| Primary completion | 15 August 2018 |
| Estimated completion | 15 August 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Egg based breakfast foods
- Non-egg based breakfast foods
Conditions studied
- PreDiabetes — all drugs for PreDiabetes →
Sponsor
Midwest Center for Metabolic and Cardiovascular Research
Who can join
Adults 18 to 74, any sex, with PreDiabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this trial is to assess the effects of whole egg consumption (12 per week), compared to energy-matched typical breakfast control foods, on insulin sensitivity and other markers of metabolic health, including fasting lipoprotein lipid levels and resting blood pressure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03332927
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PreDiabetes
Currently open trials in the same condition.
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT06967558 — The Role of Islet GLP-1 in the Pathogenesis of Prediabetes · Phase 2 · recruiting
- NCT06482944 — Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes · NA · recruiting
- NCT06989164 — Post Prandial Individual Responses to Different Foods · NA · recruiting
- NCT07254572 — Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes · Phase 4 · recruiting
Other Midwest Center for Metabolic and Cardiovascular Research trials
Trials by the same sponsor.
- NCT07293091 — Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages · NA · completed
- NCT07012317 — A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications · NA · completed
- NCT06923332 — A Trial to Assess the Effects of Diets With and Without Inulin on Energy Expenditure in Adults. · NA · completed
- NCT06494449 — Effect of Acute Intake of Meals Containing Higher vs. Lower Energy From Protein on DIT · NA · completed
- NCT06269094 — A Study to Understand How Continuous Glucose Monitors Impact Eating Behavior · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03332927 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Midwest Center for Metabolic and Cardiovascular Research
- Last refreshed: 24 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03332927.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing